My Portfolio
My Watchlists
Profile & Performance
Smart Portfolio
Find & Follow Experts
Top Lists
Top Experts
Make Better, Data Driven Investment Decisions
TipRanks tools are all you need to make data-driven investment decisions, conduct comprehensive stock research, find new investment ideas, analyze your portfolio, and follow the best-performing Wall Street experts.
About Us
Plans & Pricing

Top Coronavirus Therapeutics Stocks

Compare coronavirus therapeutics stocks. These companies are making significant advances in COVID-19 diagnostics and treatment. Get the most updated comparison by key indicators and discover each stock’s price target as well as recommendations by top Wall Street experts.
Compare up to 10 stocks

Comparison Results

Name
Price
Price Change
Price Target Upside
Market Cap
Yearly Gain
Analyst Consensus
Smart Score
Follow
REGNRegeneron
$553.24
-2.38 (-0.43%)
$708.08
(27.99% Upside)
$59.17B
-7.75%
10Buy
4Hold
0Sell
Moderate Buy
premium
GILDGilead Sciences
$67.63
-0.52 (-0.76%)
$81.29
(20.20% Upside)
$84.80B
13.87%
7Buy
3Hold
0Sell
Moderate Buy
premium
SRNESorrento Therapeutics
$6.84
-0.04 (-0.58%)
$26.00
(280.12% Upside)
$2.07B
-26.45%
1Buy
0Hold
0Sell
Moderate Buy
premium
AMGNAmgen
$207.84
1.06 (0.51%)
$240.44
(15.69% Upside)
$118.02B
-9.24%
4Buy
6Hold
1Sell
Moderate Buy
premium
ABBVAbbVie
$109.33
0.42 (0.39%)
$128.33
(17.38% Upside)
$193.21B
35.90%
10Buy
2Hold
0Sell
Strong Buy
premium
GSKGlaxoSmithKline
$39.01
0.29 (0.75%)
$98.14B
14.10%
0Buy
0Hold
1Sell
Moderate Sell
premium
LLYEli Lilly & Co
$237.88
1.19 (0.5%)
$280.83
(18.06% Upside)
$227.55B
65.57%
12Buy
0Hold
0Sell
Strong Buy
premium

Performance Comparison

Compare the performance , dividend, and cannabis stocks. Go to the Stock Comparison tool to compare more stocks on key indicators.

Coronavirus Therapeutics Stocks Latest News

Read the latest stock news and analysis from the TipRanks news team.

Recent Analysts Ratings of Coronavirus Therapeutics Stocks

Name
Analyst
Analyst Firm
Rating
Price Target
Upside / Downside
Action
Date
REGNRegeneron Pharmaceuticals
premium
premium
Buy
premium
premium
Reiterated
GILDGilead Sciences
premium
premium
Buy
premium
premium
Reiterated
AMGNAmgen Inc
premium
premium
Hold
premium
premium
Reiterated
LLYEli Lilly And Company
premium
premium
Buy
premium
premium
Upgraded
ABBVAbbvie
premium
premium
Buy
premium
premium
Reiterated
GSKGlaxoSmithKline
premium
premium
Sell
premium
premium
Reiterated
SRNESorrento Therapeutics Inc
premium
premium
Buy
premium
premium
Reiterated
REGNRegeneron Pharmaceuticals
premium
premium
Hold
premium
premium
Reiterated
AMGNAmgen Inc
premium
premium
Sell
premium
premium
Reiterated
GILDGilead Sciences
premium
premium
Hold
premium
premium
Assigned

Most Recent Earnings of Coronavirus Therapeutics Stocks

SYMBOL
Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
REGNRegeneron
Aug 05, 2021
2021 (Q2)
17.72 / 27.97
7.611
267.47% (+20.36)
GILDGilead Sciences
Jul 29, 2021
2021 (Q2)
1.74 / 1.21
-2.661
145.40% (+3.87)
SRNESorrento Therapeutics
Aug 06, 2021
2021 (Q2)
-0.36 / -0.57
-0.358
-60.34% (-0.22)
AMGNAmgen
Aug 03, 2021
2021 (Q2)
4.09 / 0.81
3.046
-73.54% (-2.24)
ABBVAbbVie
Jul 30, 2021
2021 (Q2)
3.08 / 0.42
-0.459
191.94% (+0.88)
GSKGlaxoSmithKline
Jul 28, 2021
2021 (Q2)
0.54 / 0.78
1.129
-30.91% (-0.35)
LLYEli Lilly & Co
Aug 03, 2021
2021 (Q2)
1.89 / 1.53
1.55
-1.48% (-0.02)

Coronavirus Therapeutics Stocks - FAQ

Which Coronavirus Therapeutics stocks have a "Strong Buy" analyst rating?
These Coronavirus Therapeutics stocks currently have a "Strong Buy" analyst rating consensus:
AbbVie - Strong Buy, based on 12 analyst ratings, 10 Buy, 2 Hold, and 0 Sell.
    Eli Lilly & Co - Strong Buy, based on 12 analyst ratings, 12 Buy, 0 Hold, and 0 Sell.
      Are Coronavirus Therapeutics stocks overpriced?
      Regeneron's stock price is currently $553.24, and its average 12-month price target is $708.08.
        Gilead Sciences's stock price is currently $67.63, and its average 12-month price target is $81.29.
          Sorrento Therapeutics's stock price is currently $6.84, and its average 12-month price target is $26.00.
            Amgen's stock price is currently $207.84, and its average 12-month price target is $240.44.
              AbbVie's stock price is currently $109.33, and its average 12-month price target is $128.33.
                GlaxoSmithKline's stock price is currently $39.01, and its average 12-month price target is N/A.
                  Eli Lilly & Co's stock price is currently $237.88, and its average 12-month price target is $280.83.
                    Which Coronavirus Therapeutics stocks pay dividends?
                    Regeneron does not currently pay dividends.
                      Gilead Sciences does not currently pay dividends.
                        Sorrento Therapeutics does not currently pay dividends.
                          Amgen does not currently pay dividends.
                            AbbVie does not currently pay dividends.
                              GlaxoSmithKline does not currently pay dividends.
                                Eli Lilly & Co does not currently pay dividends.